Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roche/Igen settlement?

This article was originally published in The Gray Sheet

Executive Summary

Igen hires Goldman Sachs as strategic advisor, heightening pressure on Roche as the firms discuss a possible settlement of patent litigation and Igen weighs options to maximize shareholder value - including other development partners for Igen's Origen diagnostics technology. Gaithersburg, Maryland-based Igen was awarded $505 mil. by a Maryland federal court in January after Igen filed suit in 1997, charging Roche with breaching an Origen license agreement (1"The Gray Sheet" Jan. 14, 2002, p. 31.) Roche, which said it would appeal the decision, confirms that settlement talks are ongoing...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel